Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 02:16:02 - browse：36283

MODERNA - Norwood facility — Alex Hogan/STAT

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

“We’re excited to move forward in our discussions with regulators, and hopefully continue to help address respiratory viruses globally,” Moderna President Stephen Hoge told STAT in an interview in which he acknowledged that the fall 2025 vaccine rollout is a target the company would like to hit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Novel spinal cord stimulator treats paralysis without surgery

WSS

FDA approves potent Eli Lilly obesity drug, Zepbound

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Deliver public health messages at the right time

Removing probiotics from the NICU could threaten preemies' health

AltruBio raises $225 million to develop ulcerative colitis drug

FDA approves Recor Medical high blood pressure device

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Peter Hotez and the public health issue of online harassment

Removing probiotics from the NICU could threaten preemies' health

Guidelines to prevent youth baseball injuries need more muscle

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Guidelines to prevent youth baseball injuries need more muscle

Brain technologies pose threats that are all too real, experts warn

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ambulance rides for just $100? Advisers want major billing fixes

Apple is now the first public company to be valued at $3 trillion

White House calls on federal agencies to crack down on AI abuses

knowledge

FDA approves Recor Medical high blood pressure device

FDA approves potent Eli Lilly obesity drug, Zepbound

Free speech concerns arise in wake of journal editor Eisen's firing

PBM executives asked to testify by House panel

PBM executives asked to testify by House panel

PBM executives asked to testify by House panel

Wikipedia

hotspot

entertainment

hotspot